Global Non-Alcoholic Steatohepatitis Drug Market Research Report 2016

December 2016 | 101 pages | ID: G1D7A5B2572EN
QYResearch

Abstracts

Notes:

Production, means the output of Non-Alcoholic Steatohepatitis Drug

Revenue, means the sales value of Non-Alcoholic Steatohepatitis Drug

This report studies Non-Alcoholic Steatohepatitis Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Genfit SA
• Intercept Pharmaceuticals, Inc.
• Tobira Therapeutics, Inc.
• Galmed Pharmaceuticals Ltd.

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Non-Alcoholic Steatohepatitis Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Non-Alcoholic Steatohepatitis Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Non-Alcoholic Steatohepatitis Drug Market Research Report 2016

1 NON-ALCOHOLIC STEATOHEPATITIS DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Non-Alcoholic Steatohepatitis Drug
1.2 Non-Alcoholic Steatohepatitis Drug Segment by Type
  1.2.1 Global Production Market Share of Non-Alcoholic Steatohepatitis Drug by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Non-Alcoholic Steatohepatitis Drug Segment by Application
  1.3.1 Non-Alcoholic Steatohepatitis Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Non-Alcoholic Steatohepatitis Drug Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Non-Alcoholic Steatohepatitis Drug (2011-2021)

2 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Non-Alcoholic Steatohepatitis Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Non-Alcoholic Steatohepatitis Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Non-Alcoholic Steatohepatitis Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Non-Alcoholic Steatohepatitis Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Non-Alcoholic Steatohepatitis Drug Market Competitive Situation and Trends
  2.5.1 Non-Alcoholic Steatohepatitis Drug Market Concentration Rate
  2.5.2 Non-Alcoholic Steatohepatitis Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Non-Alcoholic Steatohepatitis Drug Production and Market Share by Region (2011-2016)
3.2 Global Non-Alcoholic Steatohepatitis Drug Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Non-Alcoholic Steatohepatitis Drug Consumption by Regions (2011-2016)
4.2 North America Non-Alcoholic Steatohepatitis Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Non-Alcoholic Steatohepatitis Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Non-Alcoholic Steatohepatitis Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Non-Alcoholic Steatohepatitis Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Non-Alcoholic Steatohepatitis Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Non-Alcoholic Steatohepatitis Drug Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Non-Alcoholic Steatohepatitis Drug Production and Market Share by Type (2011-2016)
5.2 Global Non-Alcoholic Steatohepatitis Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Non-Alcoholic Steatohepatitis Drug Price by Type (2011-2016)
5.4 Global Non-Alcoholic Steatohepatitis Drug Production Growth by Type (2011-2016)

6 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Non-Alcoholic Steatohepatitis Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Non-Alcoholic Steatohepatitis Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Genfit SA
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Non-Alcoholic Steatohepatitis Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Genfit SA Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Intercept Pharmaceuticals, Inc.
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Non-Alcoholic Steatohepatitis Drug Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Tobira Therapeutics, Inc.
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Non-Alcoholic Steatohepatitis Drug Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Tobira Therapeutics, Inc. Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Galmed Pharmaceuticals Ltd.
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Non-Alcoholic Steatohepatitis Drug Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Galmed Pharmaceuticals Ltd. Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview

8 NON-ALCOHOLIC STEATOHEPATITIS DRUG MANUFACTURING COST ANALYSIS

8.1 Non-Alcoholic Steatohepatitis Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Non-Alcoholic Steatohepatitis Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Non-Alcoholic Steatohepatitis Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Non-Alcoholic Steatohepatitis Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NON-ALCOHOLIC STEATOHEPATITIS DRUG MARKET FORECAST (2016-2021)

12.1 Global Non-Alcoholic Steatohepatitis Drug Production, Revenue Forecast (2016-2021)
12.2 Global Non-Alcoholic Steatohepatitis Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Non-Alcoholic Steatohepatitis Drug Production Forecast by Type (2016-2021)
12.4 Global Non-Alcoholic Steatohepatitis Drug Consumption Forecast by Application (2016-2021)
12.5 Non-Alcoholic Steatohepatitis Drug Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non-Alcoholic Steatohepatitis Drug
Figure Global Production Market Share of Non-Alcoholic Steatohepatitis Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Non-Alcoholic Steatohepatitis Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Non-Alcoholic Steatohepatitis Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Non-Alcoholic Steatohepatitis Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Non-Alcoholic Steatohepatitis Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Non-Alcoholic Steatohepatitis Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Non-Alcoholic Steatohepatitis Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Non-Alcoholic Steatohepatitis Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Non-Alcoholic Steatohepatitis Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Non-Alcoholic Steatohepatitis Drug Production of Key Manufacturers (2015 and 2016)
Table Global Non-Alcoholic Steatohepatitis Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Non-Alcoholic Steatohepatitis Drug Production Share by Manufacturers
Figure 2016 Non-Alcoholic Steatohepatitis Drug Production Share by Manufacturers
Table Global Non-Alcoholic Steatohepatitis Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Non-Alcoholic Steatohepatitis Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Non-Alcoholic Steatohepatitis Drug Revenue Share by Manufacturers
Table 2016 Global Non-Alcoholic Steatohepatitis Drug Revenue Share by Manufacturers
Table Global Market Non-Alcoholic Steatohepatitis Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Non-Alcoholic Steatohepatitis Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Non-Alcoholic Steatohepatitis Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Non-Alcoholic Steatohepatitis Drug Product Type
Figure Non-Alcoholic Steatohepatitis Drug Market Share of Top 3 Manufacturers
Figure Non-Alcoholic Steatohepatitis Drug Market Share of Top 5 Manufacturers
Table Global Non-Alcoholic Steatohepatitis Drug Production by Regions (2011-2016)
Figure Global Non-Alcoholic Steatohepatitis Drug Production and Market Share by Regions (2011-2016)
Figure Global Non-Alcoholic Steatohepatitis Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Non-Alcoholic Steatohepatitis Drug Production Market Share by Regions
Table Global Non-Alcoholic Steatohepatitis Drug Revenue by Regions (2011-2016)
Table Global Non-Alcoholic Steatohepatitis Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Non-Alcoholic Steatohepatitis Drug Revenue Market Share by Regions
Table Global Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Non-Alcoholic Steatohepatitis Drug Consumption Market by Regions (2011-2016)
Table Global Non-Alcoholic Steatohepatitis Drug Consumption Market Share by Regions (2011-2016)
Figure Global Non-Alcoholic Steatohepatitis Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Non-Alcoholic Steatohepatitis Drug Consumption Market Share by Regions
Table North America Non-Alcoholic Steatohepatitis Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Non-Alcoholic Steatohepatitis Drug Production, Consumption, Import & Export (2011-2016)
Table China Non-Alcoholic Steatohepatitis Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Non-Alcoholic Steatohepatitis Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Non-Alcoholic Steatohepatitis Drug Production, Consumption, Import & Export (2011-2016)
Table India Non-Alcoholic Steatohepatitis Drug Production, Consumption, Import & Export (2011-2016)
Table Global Non-Alcoholic Steatohepatitis Drug Production by Type (2011-2016)
Table Global Non-Alcoholic Steatohepatitis Drug Production Share by Type (2011-2016)
Figure Production Market Share of Non-Alcoholic Steatohepatitis Drug by Type (2011-2016)
Figure 2015 Production Market Share of Non-Alcoholic Steatohepatitis Drug by Type
Table Global Non-Alcoholic Steatohepatitis Drug Revenue by Type (2011-2016)
Table Global Non-Alcoholic Steatohepatitis Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Non-Alcoholic Steatohepatitis Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Non-Alcoholic Steatohepatitis Drug by Type
Table Global Non-Alcoholic Steatohepatitis Drug Price by Type (2011-2016)
Figure Global Non-Alcoholic Steatohepatitis Drug Production Growth by Type (2011-2016)
Table Global Non-Alcoholic Steatohepatitis Drug Consumption by Application (2011-2016)
Table Global Non-Alcoholic Steatohepatitis Drug Consumption Market Share by Application (2011-2016)
Figure Global Non-Alcoholic Steatohepatitis Drug Consumption Market Share by Application in 2015
Table Global Non-Alcoholic Steatohepatitis Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Non-Alcoholic Steatohepatitis Drug Consumption Growth Rate by Application (2011-2016)
Table Genfit SA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genfit SA Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Genfit SA Non-Alcoholic Steatohepatitis Drug Market Share (2011-2016)
Table Intercept Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Intercept Pharmaceuticals, Inc. Non-Alcoholic Steatohepatitis Drug Market Share (2011-2016)
Table Tobira Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tobira Therapeutics, Inc. Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Tobira Therapeutics, Inc. Non-Alcoholic Steatohepatitis Drug Market Share (2011-2016)
Table Galmed Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galmed Pharmaceuticals Ltd. Non-Alcoholic Steatohepatitis Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Galmed Pharmaceuticals Ltd. Non-Alcoholic Steatohepatitis Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-Alcoholic Steatohepatitis Drug
Figure Manufacturing Process Analysis of Non-Alcoholic Steatohepatitis Drug
Figure Non-Alcoholic Steatohepatitis Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-Alcoholic Steatohepatitis Drug Major Manufacturers in 2015
Table Major Buyers of Non-Alcoholic Steatohepatitis Drug
Table Distributors/Traders List
Figure Global Non-Alcoholic Steatohepatitis Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Non-Alcoholic Steatohepatitis Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Non-Alcoholic Steatohepatitis Drug Production Forecast by Regions (2016-2021)
Table Global Non-Alcoholic Steatohepatitis Drug Consumption Forecast by Regions (2016-2021)
Table Global Non-Alcoholic Steatohepatitis Drug Production Forecast by Type (2016-2021)
Table Global Non-Alcoholic Steatohepatitis Drug Consumption Forecast by Application (2016-2021)